PODD - Insulet Corporation
NASDAQ
->
Healthcare
->
Medical Devices
Acton,
United States
Type: Equity
PODD price evolution
PODD
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $109.1 | $821 | $751.2 | $704.2 |
| Short term investments | ||||
| Net receivables | $375.6 | $348.6 | $320.5 | $359.7 |
| Inventory | $444.9 | $430.9 | $430.6 | $402.6 |
| Total current assets | $1860.9 | $1748.8 | $1618.4 | $1582.9 |
| Long term investments | ||||
| Property, plant & equipment | $702.9 | $677.9 | $667.7 | $664.9 |
| Goodwill & intangible assets | $150.2 | $150.2 | $150.4 | |
| Total noncurrent assets | $1132.8 | $1005.6 | $1005.3 | |
| Total investments | ||||
| Total assets | $3025.4 | $2881.6 | $2624 | $2588.2 |
| Current liabilities | ||||
| Accounts payable | $40.3 | $76.8 | $75.9 | $19.2 |
| Deferred revenue | ||||
| Short long term debt | $37.9 | $38.9 | $49.4 | |
| Total current liabilities | $506.2 | $486 | $432.4 | $451.2 |
| Long term debt | $1356.3 | $1359.9 | $1362.6 | $1366.4 |
| Total noncurrent liabilities | $1397.2 | $1400.9 | $1404.3 | |
| Total debt | $1397.8 | $1401.5 | $1415.8 | |
| Total liabilities | $1907.4 | $1883.2 | $1833.3 | $1855.5 |
| Shareholders' equity | ||||
| Retained earnings | -$60.4 | -$137.9 | -$326.5 | -$378 |
| Other shareholder equity | $7.5 | -$4.4 | -$0.5 | $8 |
| Total shareholder equity | $998.4 | $790.7 | $732.7 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $704.2 | $136.1 | $791.6 | $907.2 |
| Short term investments | $40.4 | |||
| Net receivables | $359.7 | $205.6 | $161 | $83.8 |
| Inventory | $402.6 | $346.8 | $303.2 | $154.3 |
| Total current assets | $1582.9 | $1314 | $1329.8 | $1248.7 |
| Long term investments | ||||
| Property, plant & equipment | $664.9 | $625.9 | $536.5 | $478.7 |
| Goodwill & intangible assets | $150.4 | $127.2 | $76.4 | $68.5 |
| Total noncurrent assets | $1005.3 | $937.1 | $719 | $624.2 |
| Total investments | $40.4 | |||
| Total assets | $2588.2 | $2251.1 | $2048.8 | $1872.9 |
| Current liabilities | ||||
| Accounts payable | $19.2 | $30.8 | $198.7 | $54.1 |
| Deferred revenue | ||||
| Short long term debt | $49.4 | $27.5 | $25.1 | $15.6 |
| Total current liabilities | $451.2 | $364.7 | $228.8 | $207.8 |
| Long term debt | $1366.4 | $1374.3 | $1248.8 | $1043.7 |
| Total noncurrent liabilities | $1404.3 | $1410 | $1263.7 | $1061.5 |
| Total debt | $1415.8 | $1401.8 | $1273.9 | $1059.3 |
| Total liabilities | $1855.5 | $1774.7 | $1492.5 | $1269.3 |
| Shareholders' equity | ||||
| Retained earnings | -$378 | -$584.3 | -$649.5 | -$666.3 |
| Other shareholder equity | $8 | -$17 | -$2.2 | $5.5 |
| Total shareholder equity | $732.7 | $476.4 | $556.3 | $603.6 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $543.9 | $488.5 | $441.7 | $509.8 |
| Cost of revenue | $157.6 | $134.9 | $148.6 | |
| Gross Profit | $377.1 | $330.9 | $306.8 | $361.2 |
| Operating activities | ||||
| Research & development | $53.9 | $50.2 | $42 | |
| Selling, general & administrative | $222.4 | $199.7 | $212.8 | |
| Total operating expenses | $289 | $276.3 | $249.9 | $254.8 |
| Operating income | $54.6 | $56.9 | $106.4 | |
| Income from continuing operations | ||||
| EBIT | $62.1 | $65.6 | $114.5 | |
| Income tax expense | $5.4 | -$137.5 | $3.4 | $4.5 |
| Interest expense | -$1.8 | $11 | $10.7 | $6.7 |
| Net income | ||||
| Net income | $77.5 | $188.6 | $51.5 | $103.3 |
| Income (for common shares) | $188.6 | $51.5 | $103.3 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1697.1 | $1305.3 | $1098.8 | $904.4 |
| Cost of revenue | $537.2 | $499.7 | $346.7 | $322.1 |
| Gross Profit | $1159.9 | $805.6 | $752.1 | $582.3 |
| Operating activities | ||||
| Research & development | $205 | $180.2 | $160.1 | $146.8 |
| Selling, general & administrative | $734.9 | $587.8 | $466 | $384 |
| Total operating expenses | $939.9 | $768 | $626.1 | $530.8 |
| Operating income | $220 | $37.6 | $126 | $51.5 |
| Income from continuing operations | ||||
| EBIT | $250.8 | $36.5 | $81.7 | $54.8 |
| Income tax expense | $8.3 | $5.2 | $3.7 | $2.9 |
| Interest expense | $36.2 | $26.7 | $61.2 | $45.1 |
| Net income | ||||
| Net income | $206.3 | $4.6 | $16.8 | $6.8 |
| Income (for common shares) | $206.3 | $4.6 | $16.8 | $6.8 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $188.6 | $51.5 | $103.3 | |
| Operating activities | ||||
| Depreciation | $19.2 | $18.8 | $18.8 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $17 | $14.2 | $12.6 | |
| Total cash flows from operations | $96.5 | $87.6 | $45.2 | |
| Investing activities | ||||
| Capital expenditures | -$24.9 | -$24 | -$56.7 | |
| Investments | ||||
| Total cash flows from investing | -$78.2 | -$24.9 | -$24 | -$31.6 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $7.1 | $5.8 | $9 | |
| Net borrowings | -$6.9 | -$14.9 | -$7 | |
| Total cash flows from financing | -$7.2 | -$0.9 | -$14.1 | $2.2 |
| Effect of exchange rate | $1.2 | -$0.9 | -$2.5 | $3 |
| Change in cash and equivalents | $198.4 | $69.8 | $47 | $18.8 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $206.3 | $4.6 | $16.8 | $6.8 |
| Operating activities | ||||
| Depreciation | $72.8 | $63.2 | $57.4 | $55.4 |
| Business acquisitions & disposals | -$3 | -$26 | ||
| Stock-based compensation | $48.3 | $40.9 | $34.4 | $35.9 |
| Total cash flows from operations | $145.7 | $119 | -$68.1 | $84 |
| Investing activities | ||||
| Capital expenditures | -$109.2 | -$135.8 | -$111.9 | -$129 |
| Investments | -$7.2 | -$7.8 | $40 | $180.5 |
| Total cash flows from investing | -$119.4 | -$191.1 | -$82.7 | $14 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $26.9 | $16.3 | $23.5 | $509.2 |
| Net borrowings | -$27.3 | -$39.8 | $45.4 | $128.3 |
| Total cash flows from financing | -$13.6 | -$40.3 | $40.7 | $605.5 |
| Effect of exchange rate | $1.8 | -$4.3 | -$5.5 | $4.8 |
| Change in cash and equivalents | $14.5 | -$116.7 | -$115.6 | $708.3 |
News
Fundamentals
| Market cap | $19.07B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 70.14M |
| Revenue | $1.98B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $420.90M |
| Revenue Q/Q | 25.70% |
| Revenue Y/Y | 27.42% |
| P/E ratio | 45.30 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 9.61 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 1.56 |
| EPS | $6.00 |
|---|---|
| ROA | 15.14% |
| ROE | N/A |
| Debt/Equity | 2.53 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.68 |
| Quick ratio | 2.80 |